BioCardia, Inc.
BCDA
$1.40
$0.010.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.48M | -2.05M | -2.71M | -2.30M | -1.74M |
| Total Depreciation and Amortization | 4.00K | 5.00K | 12.00K | 15.00K | 16.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 180.00K | 197.00K | 267.00K | 271.00K | 269.00K |
| Change in Net Operating Assets | -373.00K | 198.00K | 815.00K | -563.00K | -1.16M |
| Cash from Operations | -1.67M | -1.65M | -1.62M | -2.57M | -2.61M |
| Capital Expenditure | 0.00 | -1.00K | -- | -1.00K | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -1.00K | -- | -1.00K | -2.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.78M | 1.70M | 212.00K | 39.00K | 7.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -804.00K | -14.00K | -16.00K | -24.00K | -1.08M |
| Cash from Financing | 5.98M | 1.68M | 196.00K | 15.00K | 6.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.31M | 31.00K | -1.42M | -2.56M | 3.51M |